These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 27855220)

  • 21. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study.
    Apiwattanakul M; Kasemsuk C
    Mult Scler Relat Disord; 2014 Jan; 3(1):61-6. PubMed ID: 25877974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A differential diagnosis of central nervous system demyelination: beyond multiple sclerosis.
    Eckstein C; Saidha S; Levy M
    J Neurol; 2012 May; 259(5):801-16. PubMed ID: 21932127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
    Gebregiworgis T; Nielsen HH; Massilamany C; Gangaplara A; Reddy J; Illes Z; Powers R
    J Proteome Res; 2016 Feb; 15(2):659-66. PubMed ID: 26759122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipidomic profiling of plasma samples from patients with mitochondrial disease.
    Ren C; Liu J; Zhou J; Liang H; Zhu Y; Wang Q; Leng Y; Zhang Z; Yuan Y; Wang Z; Yin Y
    Biochem Biophys Res Commun; 2018 Jun; 500(2):124-131. PubMed ID: 29627572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
    Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
    Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic severe recurrent transverse myelitis: a restricted variant of neuromyelitis optica.
    Chan KH; Tsang KL; Fong GC; Cheung RT; Ho SL
    Clin Neurol Neurosurg; 2005 Feb; 107(2):132-5. PubMed ID: 15708229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
    Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ
    J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases.
    Zhao D; Zhang W; Ma X; Zhao R; Yao L; Lu J; Yan X; Bai M; Zhang G; Li H; Guo J
    Vaccine X; 2023 Dec; 15():100388. PubMed ID: 37767538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
    Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
    Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal cord atrophy in neuromyelitis optica spectrum disorders.
    Wang Y; Wang Y; Tan S; Lu Z
    Mult Scler Relat Disord; 2016 Jul; 8():9-10. PubMed ID: 27456868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
    Dos Passos GR; Sato DK; Becker J; Fujihara K
    Mediators Inflamm; 2016; 2016():5314541. PubMed ID: 26941483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM; Lucchinetti CF
    Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese.
    Chan KH; Ramsden DB; Yu YL; Kwok KH; Chu AC; Ho PW; Kwan JS; Lee R; Lim E; Kung MH; Ho SL
    Eur J Neurol; 2009 Mar; 16(3):310-6. PubMed ID: 19138340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
    Sinclair AJ; Wienholt L; Tantsis E; Brilot F; Dale RC
    Dev Med Child Neurol; 2013 Jan; 55(1):71-5. PubMed ID: 23095051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations.
    Kowarik MC; Dzieciatkowska M; Wemlinger S; Ritchie AM; Hemmer B; Owens GP; Bennett JL
    J Neuroinflammation; 2015 Jan; 12():19. PubMed ID: 25626447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 17 alone is not a discriminant biomarker in early demyelinating spectrum disorders.
    Lebrun C; Cohen M; Pignolet B; Seitz-Polski B; Bucciarelli F; Benzaken S; Kantarci O; Siva A; Okuda D; Pelletier D; Brassat D; ;
    J Neurol Sci; 2016 Sep; 368():334-6. PubMed ID: 27538659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolomics of Cerebrospinal Fluid Amino and Fatty Acids in Early Stages of Multiple Sclerosis.
    Židó M; Kačer D; Valeš K; Zimová D; Štětkářová I
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
    Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
    J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.